Search results
What’s driving the anti-vax movement? | The Excerpt
USA Today· 2 days agoCORRECTION: This episode has been updated to remove an incorrect reference to the HPV vaccine. On Sunday’s episode of The Excerpt podcast: Whether...
Looking back at former Trump fixer on the stand in hush money trial: Who is Michael Cohen?
USA TODAY via Yahoo News· 6 hours agoHe started his sentence in May 2019, but was sent home early for house arrest due to the COVID-19 pandemic. Where did Michael Cohen go to law school? Michael ...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 2 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 20 hours agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
REPUBLICAN RUNOFF 2024 | Texas House District 1 Representative | Texarkana Gazette
Texarkana Gazette· 3 hours agoRepublicans will choose between Texas House District 1 incumbent Rep. Gary VanDeaver and challenger...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 5 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
WFRV 5 Green Bay· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19
American Express Stock Still Looks Attractive Despite Soaring 29% This Year
Motley Fool via Yahoo Finance· 13 hours agoThe company has increased its dividend at rates between 17% and 21% each year since 2022. Further,...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 12 hours agoModerna Moderna is one of the captains of a sinking ship. As a leader in the COVID-19 vaccine...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 11 hours agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...